Skip to main content

Armistice Capital, LLC

13F filer · CIK 0001601086
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$8.17BU.S. long equity reported on 13F
Positions322167 new · 93 closed
Net flow last quarter-$111MBuys minus sells
Top 10 positions weight12.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026322 positions
MDGLMadrigal Pharmaceuticals, Inc.$155M1.89%1.25%+8.9%Q3 2016
SUPNSupernus Pharmaceuticals, Inc.$123M1.51%4.55%+39.6%Q4 2019
CYTKCytokinetics Inc$102M1.25%0.97%+57.1%Q1 2024
INCYIncyte Corp$102M1.25%0.45%+37.0%Q3 2017
NBIXNeurocrine Biosciences Inc$90.3M1.10%0.53%-26.0%Q1 2022
TVTXTravere Therapeutics, Inc.$89.3M1.09%1.67%-67.9%Q1 2021
AGIOAgios Pharmaceuticals, Inc.$89.1M1.09%4.03%-11.6%Q3 2022
PTCTPTC Therapeutics, Inc.$87.4M1.07%1.29%-48.4%Q4 2018
UNHUnitedhealth Group Inc$76.1M0.93%0.02%+23.7%Q3 2019
FRPTFreshpet, Inc.$74.5M0.91%2.59%+15.3%Q3 2015
DYNDyne Therapeutics, Inc.$68.6M0.84%1.86%-2.8%Q2 2023
AMZNAmazon Com Inc$67.8M0.83%0.00%+8.6%Q4 2017
IMVTImmunovant, Inc.$66.9M0.82%0.84%-51.3%Q3 2023
RIGLRigel Pharmaceuticals Inc$65.4M0.80%9.04%+30.6%Q2 2020
TMOThermo Fisher Scientific Inc.$61.4M0.75%0.03%+33.9%Q1 2020
IRWDIronwood Pharmaceuticals Inc$58.7M0.72%8.43%-7.3%Q3 2023
HRMYHarmony Biosciences Holdings, Inc.$56.9M0.70%2.69%-3.7%Q4 2025
REGNRegeneron Pharmaceuticals, Inc.$56M0.69%0.10%+148.6%Q1 2017
NKTRNektar Therapeutics$50.5M0.62%3.55%+25.3%Q2 2024
MLYSMineralys Therapeutics, Inc.$46.8M0.57%1.96%+47.6%Q2 2025
SNYSanofi$45.4M0.56%0.09%+254.7%Q2 2016
IMCRImmunocore Holdings plc$45.3M0.55%2.77%+20.2%Q1 2022
GOOGLAlphabet Inc.$45.2M0.55%0.00%+6.7%Q3 2021
SLDBSolid Biosciences Inc.$42.7M0.52%4.07%+33.7%Q2 2018
MDBMongoDB, Inc.$42M0.51%0.16%+16.7%Q3 2022
KURAKura Oncology, Inc.$40.3M0.49%4.13%-1.6%Q4 2022
XRAYDENTSPLY SIRONA Inc.$39M0.48%1.84%+22.4%Q3 2021
UBERUber Technologies, Inc$35.9M0.44%0.02%-4.0%Q1 2020
AXGNAxogen, Inc.$35.8M0.44%1.44%-17.2%Q3 2024
IRONDisc Medicine, Inc.$33.6M0.41%1.20%-14.2%Q3 2024
GTLBGitlab Inc.$32.8M0.40%Not reported+4.4%Q2 2025
FIVNFive9, Inc.$32.7M0.40%2.06%-3.5%Q4 2021
HUBSHubspot Inc$32.5M0.40%0.36%+38.5%Q2 2022
ALGNAlign Technology Inc$30.4M0.37%0.25%+14.1%Q4 2025
MSFTMicrosoft Corp$30.1M0.37%0.00%+64.9%Q3 2020
OFIXOrthofix Medical Inc.$29.8M0.36%8.01%+20.9%Q4 2022
HUMHumana Inc$28.8M0.35%0.06%-48.7%Q1 2024
ANGOAngiodynamics Inc$28.6M0.35%5.27%+17.6%Q4 2023
WATWaters Corp$28.1M0.34%0.08%NewQ2 2026
VSTMVerastem, Inc.$26.8M0.33%7.76%+53.0%Q3 2021
FDMT4D Molecular Therapeutics, Inc.$26.6M0.33%3.62%Not reportedQ3 2024
NTLAIntellia Therapeutics, Inc.$25.4M0.31%1.07%+346.4%Q1 2025
WYNNWynn Resorts Ltd$25.3M0.31%0.25%+50.4%Q3 2020
TMCITreace Medical Concepts, Inc.$25.3M0.31%9.81%Not reportedQ4 2023
AUTLAutolus Therapeutics plc$24M0.29%5.64%-5.1%Q4 2022
ARVNArvinas, Inc.$23.2M0.28%4.28%+41.4%Q2 2025
MGNXMacrogenics Inc$23.1M0.28%7.87%-16.7%Q4 2021
ANROAlto Neuroscience, Inc.$22.8M0.28%2.46%-5.3%Q4 2024
TOSTToast, Inc.$22.6M0.28%0.37%+40.4%Q1 2022
PATHUiPath, Inc.$21.7M0.27%Not reported+55.7%Q2 2023
Q1 2026Reported May 15, 2026248 positions
TVTXTravere Therapeutics, Inc.$146M2.59%5.30%+30.1%Q1 2021
PTCTPTC Therapeutics, Inc.$141M2.51%2.50%-26.0%Q4 2018
MDGLMadrigal Pharmaceuticals, Inc.$139M2.46%1.15%-0.4%Q3 2016
SUPNSupernus Pharmaceuticals, Inc.$98M1.74%3.27%-31.4%Q4 2019
NBIXNeurocrine Biosciences Inc$95.4M1.70%0.72%-11.7%Q1 2022
AGIOAgios Pharmaceuticals, Inc.$91.9M1.63%4.58%-10.5%Q3 2022
IMVTImmunovant, Inc.$88.6M1.57%1.75%-38.0%Q3 2023
FRPTFreshpet, Inc.$64.5M1.15%2.22%-15.6%Q3 2015
INCYIncyte Corp$61.8M1.10%0.33%-40.2%Q3 2017
DYNDyne Therapeutics, Inc.$57.6M1.02%1.92%-2.3%Q2 2023
AMZNAmazon Com Inc$54.6M0.97%0.00%-28.7%Q4 2017
IRWDIronwood Pharmaceuticals Inc$52.7M0.94%9.13%-6.2%Q3 2023
CYTKCytokinetics Inc$50.4M0.90%0.62%-23.0%Q1 2024
HRMYHarmony Biosciences Holdings, Inc.$45.5M0.81%2.81%+224.8%Q4 2025
TMOThermo Fisher Scientific Inc.$45M0.80%0.02%+45.6%Q1 2020
NKTRNektar Therapeutics$41.6M0.74%2.84%-3.0%Q2 2024
UNHUnitedhealth Group Inc$40M0.71%0.02%Not reportedQ3 2019
UBERUber Technologies, Inc$37.3M0.66%0.03%+83.5%Q1 2020
IMCRImmunocore Holdings plc$35.8M0.64%2.34%+8.2%Q1 2022
XRAYDENTSPLY SIRONA Inc.$34.8M0.62%1.50%-58.9%Q3 2021
RIGLRigel Pharmaceuticals Inc$34.6M0.62%6.93%+53.1%Q2 2020
IRONDisc Medicine, Inc.$34.3M0.61%1.40%+7.3%Q3 2024
GOOGLAlphabet Inc.$34.1M0.61%0.00%-39.7%Q3 2021
MLYSMineralys Therapeutics, Inc.$31.9M0.57%1.43%+74.0%Q2 2025
HUBSHubspot Inc$31.4M0.56%0.25%+89.1%Q2 2022
AXGNAxogen, Inc.$31M0.55%1.76%Not reportedQ3 2024
OFIXOrthofix Medical Inc.$31M0.55%6.69%+2.0%Q4 2022
KURAKura Oncology, Inc.$30.4M0.54%4.21%-24.3%Q4 2022
AVNSAvanos Medical, Inc.$28M0.50%4.29%-37.5%Q3 2020
REGNRegeneron Pharmaceuticals, Inc.$27.9M0.50%0.04%-57.0%Q1 2017
ALGNAlign Technology Inc$27.1M0.48%0.22%+107.6%Q4 2025
MDBMongoDB, Inc.$26.3M0.47%0.13%+118.3%Q3 2022
BABAAlibaba Group Holding Ltd$25.6M0.46%0.01%-36.1%Q4 2020
MDLNMedline Inc.$25.1M0.45%Not reported+873.6%Q4 2025
KALVKalVista Pharmaceuticals, Inc.$24.9M0.44%2.41%+54.5%Q4 2025
DDOGDatadog, Inc.$24.6M0.44%0.27%-14.7%Q4 2021
HUMHumana Inc$24.5M0.44%0.12%+97.1%Q1 2024
SSentinelOne, Inc.$24.4M0.43%Not reported-21.7%Q3 2022
VSTMVerastem, Inc.$24.3M0.43%5.23%+29.9%Q3 2021
FIVNFive9, Inc.$24.2M0.43%2.08%-20.4%Q4 2021
ISRGIntuitive Surgical Inc$24M0.43%0.01%-14.8%Q1 2022
GRFSGrifols SA$24M0.43%Not reported+8.0%Q1 2024
PENNPENN Entertainment, Inc.$23.7M0.42%1.18%-49.0%Q4 2023
SLDBSolid Biosciences Inc.$23M0.41%3.25%+22.5%Q2 2018
GTLBGitlab Inc.$22.3M0.40%Not reported+19.8%Q2 2025
AUTLAutolus Therapeutics plc$21.8M0.39%5.94%-9.7%Q4 2022
ANGOAngiodynamics Inc$21.3M0.38%4.52%+9.9%Q4 2023
ARVNArvinas, Inc.$21M0.37%3.07%+9.9%Q2 2025
TSMTaiwan Semiconductor Manufacturing Co Ltd$20.7M0.37%0.00%+22.5%Q1 2023
ANROAlto Neuroscience, Inc.$20.5M0.36%2.60%-40.6%Q4 2024
Q4 2025Reported Feb 17, 2026352 positions
PTCTPTC Therapeutics, Inc.$213M2.53%3.44%-14.5%Q4 2018
MDGLMadrigal Pharmaceuticals, Inc.$155M1.84%1.16%+121.5%Q3 2016
IMVTImmunovant, Inc.$146M1.74%2.83%-1.5%Q3 2023
TVTXTravere Therapeutics, Inc.$144M1.71%4.14%-44.0%Q1 2021
SUPNSupernus Pharmaceuticals, Inc.$137M1.63%4.81%-2.5%Q4 2019
NBIXNeurocrine Biosciences Inc$116M1.38%0.82%+17.7%Q1 2022
INCYIncyte Corp$108M1.29%0.55%-5.9%Q3 2017
AMZNAmazon Com Inc$84.9M1.01%0.00%+18.8%Q4 2017
XRAYDENTSPLY SIRONA Inc.$83.4M0.99%3.66%+27.2%Q3 2021
AGIOAgios Pharmaceuticals, Inc.$82.6M0.98%5.19%+297.4%Q3 2022
FRPTFreshpet, Inc.$79M0.94%2.65%+5.0%Q3 2015
KVUEKenvue Inc.$68.9M0.82%0.21%Not reportedQ2 2023
GEHCGE HealthCare Technologies Inc.$65M0.77%0.17%-0.4%Q3 2024
REGNRegeneron Pharmaceuticals, Inc.$64.8M0.77%0.09%-32.9%Q1 2017
DYNDyne Therapeutics, Inc.$63.6M0.76%1.97%+6.1%Q2 2023
CYTKCytokinetics Inc$63.1M0.75%0.81%-17.1%Q1 2024
GOOGLAlphabet Inc.$61.5M0.73%0.00%-14.9%Q3 2021
MSFTMicrosoft Corp$57.2M0.68%0.00%+35.6%Q3 2020
IRWDIronwood Pharmaceuticals Inc$54M0.64%9.83%-0.8%Q3 2023
KURAKura Oncology, Inc.$51.3M0.61%5.62%+5.7%Q4 2022
ELFe.l.f. Beauty, Inc.$50M0.60%1.11%+394.9%Q4 2024
GSKGSK plc$49M0.58%0.02%Not reportedQ4 2017
ARGXArgenx SE$48.8M0.58%0.09%Not reportedQ2 2020
BABAAlibaba Group Holding Ltd$46.8M0.56%0.00%+104.6%Q4 2020
SBUXStarbucks Corp$46.3M0.55%0.05%+54.4%Q2 2021
PENNPENN Entertainment, Inc.$45.7M0.54%2.32%+47.2%Q4 2023
OFIXOrthofix Medical Inc.$40.1M0.48%6.65%+18.4%Q4 2022
FIVNFive9, Inc.$40.1M0.48%2.59%Not reportedQ4 2021
IRONDisc Medicine, Inc.$39.7M0.47%1.32%+14.5%Q3 2024
IMCRImmunocore Holdings plc$38.1M0.45%2.17%+33.3%Q1 2022
TMOThermo Fisher Scientific Inc.$36.4M0.43%0.02%+14.2%Q1 2020
SSentinelOne, Inc.$36.3M0.43%Not reported+118.0%Q3 2022
AVNSAvanos Medical, Inc.$35.9M0.43%6.89%+28.0%Q3 2020
RIGLRigel Pharmaceuticals Inc$35.8M0.43%4.57%+15.5%Q2 2020
AUTLAutolus Therapeutics plc$34.8M0.41%6.58%+12.2%Q4 2022
ISRGIntuitive Surgical Inc$34.6M0.41%0.02%+49.0%Q1 2022
DDOGDatadog, Inc.$33.3M0.40%0.31%+21.0%Q4 2021
VERAVera Therapeutics, Inc.$33.1M0.39%1.02%+22.0%Q4 2024
SNYSanofi$32.8M0.39%0.06%+10.5%Q2 2016
GTLBGitlab Inc.$32.2M0.38%Not reported+127.9%Q2 2025
AXGNAxogen, Inc.$30.6M0.36%1.98%-22.0%Q3 2024
ANROAlto Neuroscience, Inc.$27.3M0.33%4.81%-6.1%Q4 2024
VSTMVerastem, Inc.$27.3M0.32%4.55%+68.7%Q3 2021
HUBSHubspot Inc$27.3M0.32%0.13%+51.1%Q2 2022
MDTMedtronic plc$26.1M0.31%0.02%+2.3%Q2 2020
GRFSGrifols SA$25.9M0.31%Not reported+23.8%Q1 2024
NKTRNektar Therapeutics$25.2M0.30%2.92%+122.4%Q2 2024
NKENIKE, Inc.$25.1M0.30%0.02%+399.0%Q1 2019
PATHUiPath, Inc.$25M0.30%Not reported+13.4%Q2 2023
MLYSMineralys Therapeutics, Inc.$24.5M0.29%0.83%+33.2%Q2 2025
Q3 2025Reported Nov 17, 2025314 positions
PTCTPTC Therapeutics, Inc.$201M2.98%4.10%-30.8%Q4 2018
TVTXTravere Therapeutics, Inc.$161M2.38%7.52%-24.3%Q1 2021
SUPNSupernus Pharmaceuticals, Inc.$136M2.01%4.97%-41.1%Q4 2019
INCYIncyte Corp$99M1.47%0.60%-12.6%Q3 2017
NBIXNeurocrine Biosciences Inc$97.8M1.45%0.70%+3.1%Q1 2022
IMVTImmunovant, Inc.$94.1M1.40%3.34%+12.2%Q3 2023
XRAYDENTSPLY SIRONA Inc.$72.8M1.08%2.88%+1044.0%Q3 2021
REGNRegeneron Pharmaceuticals, Inc.$70.4M1.04%0.13%+25.2%Q1 2017
FRPTFreshpet, Inc.$68M1.01%2.53%+118.4%Q3 2015
AMZNAmazon Com Inc$67.9M1.01%0.00%+41.0%Q4 2017
CYTKCytokinetics Inc$65.8M0.98%1.00%-8.8%Q1 2024
GEHCGE HealthCare Technologies Inc.$59.7M0.89%0.17%+5.1%Q3 2024
EXKEndeavour Silver Corp$56.4M0.84%0.39%+38.9%Q3 2020
GOOGLAlphabet Inc.$56.1M0.83%0.00%+21.2%Q3 2021
MDGLMadrigal Pharmaceuticals, Inc.$55M0.82%0.53%-3.2%Q3 2016
FIVNFive9, Inc.$48.4M0.72%2.56%+8.9%Q4 2021
MSFTMicrosoft Corp$45.2M0.67%0.00%+4.2%Q3 2020
ARGXArgenx SE$42.8M0.63%0.10%-27.5%Q2 2020
TMCITreace Medical Concepts, Inc.$42.4M0.63%10.00%+0.9%Q4 2023
KURAKura Oncology, Inc.$41.3M0.61%5.37%-24.7%Q4 2022
NVONovo Nordisk A S$40.8M0.61%Not reportedNot reportedQ4 2022
PENNPENN Entertainment, Inc.$40.5M0.60%1.44%+48.8%Q4 2023
DYNDyne Therapeutics, Inc.$38.8M0.57%2.15%+19.7%Q2 2023
MDBMongoDB, Inc.$34.9M0.52%0.14%+8.6%Q3 2022
OFIXOrthofix Medical Inc.$32.7M0.49%5.66%-24.9%Q4 2022
AGIOAgios Pharmaceuticals, Inc.$30.7M0.45%1.31%-34.6%Q3 2022
SBUXStarbucks Corp$30.1M0.45%0.03%Not reportedQ2 2021
IMCRImmunocore Holdings plc$29.9M0.44%1.63%+21.5%Q1 2022
BMYBristol Myers Squibb Co$29.3M0.43%0.03%Not reportedQ4 2019
AVNSAvanos Medical, Inc.$28.9M0.43%5.39%+22.8%Q3 2020
SNYSanofi$28.9M0.43%0.05%Not reportedQ2 2016
IRONDisc Medicine, Inc.$28.8M0.43%1.25%Not reportedQ3 2024
DDOGDatadog, Inc.$28.8M0.43%0.26%+34.7%Q4 2021
BABAAlibaba Group Holding Ltd$27.9M0.41%0.00%+169.0%Q4 2020
TMOThermo Fisher Scientific Inc.$26.7M0.40%0.01%+83.6%Q1 2020
AUTLAutolus Therapeutics plc$25.4M0.38%5.86%+30.0%Q4 2022
MDTMedtronic plc$25.3M0.37%0.02%+0.5%Q2 2020
NBISNebius Group N.V.$23.9M0.36%0.09%+72.0%Q4 2024
BCYCBicycle Therapeutics PLC$23M0.34%4.30%+6.4%Q1 2023
GRFSGrifols SA$22.3M0.33%Not reported-69.4%Q1 2024
CVSCVS HEALTH Corp$22M0.33%0.02%Not reportedQ4 2017
AXGNAxogen, Inc.$21.4M0.32%2.60%+8.0%Q3 2024
IRWDIronwood Pharmaceuticals Inc$21.2M0.31%9.93%Not reportedQ3 2023
HUBSHubspot Inc$21.1M0.31%0.09%+103.7%Q2 2022
RIGLRigel Pharmaceuticals Inc$20.5M0.30%4.04%-54.8%Q2 2020
VYGRVoyager Therapeutics, Inc.$19.6M0.29%7.57%-12.5%Q2 2018
SSentinelOne, Inc.$19.6M0.29%Not reported-10.1%Q3 2022
DTDynatrace, Inc.$19.4M0.29%0.13%+78.6%Q4 2020
MLYSMineralys Therapeutics, Inc.$19.3M0.29%0.64%+185.2%Q2 2025
VSTMVerastem, Inc.$18.5M0.27%3.14%-1.9%Q3 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.